iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionCentiva Capital, LP
Latest Disclosed Ownership3,000 shares
Latest Disclosed Value $ 506,550
Centiva Capital, LP ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 14, 2026 - Centiva Capital, LP filed a 13F-HR form disclosing ownership of 3,000 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $506,550 USD as of March 31, 2026. The entity filed a previous 13F-HR on May 15, 2025 disclosing 0 shares of iShares Trust - iShares Biotechnology ETF. The current value of the position is $393,150 USD.

Centiva Capital, LP has a history of taking positions in derivatives of the underlying security (0JGB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0JGB / iShares Trust - iShares Biotechnology ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,000 3,000 507 0.0037
2025-05-15 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 0 -4,739 -100.00 0 -100.00
2025-02-14 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,739 4,739 627 0.0129
2024-11-14 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -13,250 -100.00 0 -100.00
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,250 13,250 1,819 0.0308
2024-05-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 0 -2,651 -100.00 0 -100.00
2024-02-14 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,651 2,651 360 0.0085
2021-05-17 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -74,979 -100.00 0 -100.00
2021-02-16 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 74,979 -49,991 -40.00 11,359 -32.88 0.4437
2020-11-16 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 124,970 50,059 66.82 16,923 65.26 1.1109
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 74,911 -88,579 -54.18 10,240 -41.86 0.6174
2020-05-15 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 163,490 125,165 326.59 17,614 281.34 0.7904
2020-02-14 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 38,325 34,720 963.11 4,619 1,186.63 0.2259
2019-11-13 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,605 877 32.15 359 20.47 0.0219
2019-08-13 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,728 -45 -1.62 298 -3.87 0.0178
2019-05-14 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,773 -6,819 -71.09 310 -66.49 0.0208
2019-02-13 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 9,592 9,592 925 0.0731
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-14 2024-12-31 13F ISHARES TR ISHARES BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F ISHARES TR ISHARES BIOTECH Call 32,000 40.97 4,659 49.57 n/a n/a n/a
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH Call 22,700 3,116 n/a n/a n/a
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F ISHARES TR NASDAQ BIOTECH Call 2,800 0.00 302 -10.39 n/a n/a n/a
2020-02-14 2019-12-31 13F ISHARES TR NASDAQ BIOTECH Call 2,800 337 n/a n/a n/a
2019-05-14 2019-03-31 13F ISHARES TR NASDAQ BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-13 2018-12-31 13F ISHARES TR NASDAQ BIOTECH Call 10,100 -66.33 974 -73.37 n/a n/a n/a
2018-11-14 2018-09-30 13F ISHARES TR NASDAQ BIOTECH Call 30,000 3,658 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-15 2025-03-31 13F ISHARES TR ISHARES BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F ISHARES TR ISHARES BIOTECH Put 4,600 -51.06 608 -55.56 n/a n/a n/a
2024-11-14 2024-09-30 13F ISHARES TR ISHARES BIOTECH Put 9,400 -73.30 1,369 -71.68 n/a n/a n/a
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH Put 35,200 4,832 n/a n/a n/a
2024-05-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F ISHARES TR ISHARES BIOTECH Put 2,400 326 n/a n/a n/a
2021-05-17 2021-03-31 13F ISHARES TR NASDAQ BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F ISHARES TR NASDAQ BIOTECH Put 75,000 0.00 11,362 11.87 n/a n/a n/a
2020-11-16 2020-09-30 13F ISHARES TR NASDAQ BIOTECH Put 75,000 0.00 10,156 -0.94 n/a n/a n/a
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH Put 75,000 -76.56 10,252 -70.30 n/a n/a n/a
2020-05-15 2020-03-31 13F ISHARES TR NASDAQ BIOTECH Put 319,900 28.73 34,522 15.25 n/a n/a n/a
2020-02-14 2019-12-31 13F ISHARES TR NASDAQ BIOTECH Put 248,500 6,802.78 29,953 8,266.76 n/a n/a n/a
2019-11-13 2019-09-30 13F ISHARES TR NASDAQ BIOTECH Put 3,600 -28.00 358 -34.43 n/a n/a n/a
2019-08-13 2019-06-30 13F ISHARES TR NASDAQ BIOTECH Put 5,000 -50.00 546 -51.16 n/a n/a n/a
2019-05-14 2019-03-31 13F ISHARES TR NASDAQ BIOTECH Put 10,000 -30.56 1,118 -19.51 n/a n/a n/a
2019-02-13 2018-12-31 13F ISHARES TR NASDAQ BIOTECH Put 14,400 227.27 1,389 159.14 n/a n/a n/a
2018-11-14 2018-09-30 13F ISHARES TR NASDAQ BIOTECH Put 4,400 536 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.